Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60

1.

Gene expression profiling identifies potential molecular markers of papillary thyroid carcinoma.

Reyes I, Reyes N, Suriano R, Iacob C, Suslina N, Policastro A, Moscatello A, Schantz S, Tiwari RK, Geliebter J.

Cancer Biomark. 2019;24(1):71-83. doi: 10.3233/CBM-181758.

PMID:
30614796
2.

Ethanol Enhances Estrogen Mediated Angiogenesis in Breast Cancer.

Maniyar R, Chakraborty S, Suriano R.

J Cancer. 2018 Oct 6;9(21):3874-3885. doi: 10.7150/jca.25581. eCollection 2018.

3.

Analgesic effects of intravenous flunixin and intrafunicular lidocaine or their combination for castration of lambs.

Straticò P, Varasano V, Suriano R, Mariscoli M, Robbe D, Giammarco M, Vignola G, Petrizzi L.

Vet Rec Open. 2018 Jul 6;5(1):e000266. doi: 10.1136/vetreco-2017-000266. eCollection 2018.

4.

Correction to Thermoresponsive Polymer Micropatterns Fabricated by Dip-Pen Nanolithography for a Highly Controllable Substrate with Potential Cellular Applications.

Laing S, Suriano R, Lamprou DA, Smith CA, Dalby MJ, Mabbott S, Faulds K, Graham D.

ACS Appl Mater Interfaces. 2017 Mar 8;9(9):8432. doi: 10.1021/acsami.7b01811. Epub 2017 Feb 27. No abstract available.

PMID:
28240854
5.

Long-Term Outcome of En Bloc Extensive Resection of the Penis and Prepuce Associated with a Permanent Perineal Urethrostomy in a Gelding Affected by Squamous Cell Carcinoma.

Straticò P, Varasano V, Celani G, Suriano R, Petrizzi L.

Case Rep Vet Med. 2016 Sep 27;2016:6989450. doi: 10.1155/2016/6989450. eCollection 2016.

6.

Thermoresponsive Polymer Micropatterns Fabricated by Dip-Pen Nanolithography for a Highly Controllable Substrate with Potential Cellular Applications.

Laing S, Suriano R, Lamprou DA, Smith CA, Dalby MJ, Mabbott S, Faulds K, Graham D.

ACS Appl Mater Interfaces. 2016 Sep 21;8(37):24844-52. doi: 10.1021/acsami.6b03860. Epub 2016 Sep 7. Erratum in: ACS Appl Mater Interfaces. 2017 Mar 8;9(9):8432.

7.

Nanomechanical probing of soft matter through hydrophobic AFM tips fabricated by two-photon polymerization.

Suriano R, Zandrini T, De Marco C, Osellame R, Turri S, Bragheri F.

Nanotechnology. 2016 Apr 15;27(15):155702. doi: 10.1088/0957-4484/27/15/155702. Epub 2016 Feb 29.

PMID:
26926558
8.

Hyperactive ERK and persistent mTOR signaling characterize vemurafenib resistance in papillary thyroid cancer cells.

Hanly EK, Tuli NY, Bednarczyk RB, Suriano R, Geliebter J, Moscatello AL, Darzynkiewicz Z, Tiwari RK.

Oncotarget. 2016 Feb 23;7(8):8676-87. doi: 10.18632/oncotarget.6779.

9.

PLX4032 Mediated Melanoma Associated Antigen Potentiation in Patient Derived Primary Melanoma Cells.

George AL, Suriano R, Rajoria S, Osso MC, Tuli N, Hanly E, Geliebter J, Arnold AN, Wallack M, Tiwari RK.

J Cancer. 2015 Oct 29;6(12):1320-30. doi: 10.7150/jca.11126. eCollection 2015.

10.

Disruption of mutated BRAF signaling modulates thyroid cancer phenotype.

Hanly EK, Rajoria S, Darzynkiewicz Z, Zhao H, Suriano R, Tuli N, George AL, Bednarczyk R, Shin EJ, Geliebter J, Tiwari RK.

BMC Res Notes. 2014 Mar 28;7:187. doi: 10.1186/1756-0500-7-187.

11.

Follow-up analysis of a randomized phase III immunotherapeutic clinical trial on melanoma.

Suriano R, Rajoria S, George AL, Geliebter J, Tiwari RK, Wallack M.

Mol Clin Oncol. 2013 May;1(3):466-472. Epub 2013 Mar 20.

12.

Rheological and mechanical behavior of polyacrylamide hydrogels chemically crosslinked with allyl agarose for two-dimensional gel electrophoresis.

Suriano R, Griffini G, Chiari M, Levi M, Turri S.

J Mech Behav Biomed Mater. 2014 Feb;30:339-46. doi: 10.1016/j.jmbbm.2013.12.006. Epub 2013 Dec 11.

PMID:
24368174
13.

Interlinking of hypoxia and estrogen in thyroid cancer progression.

Rajoria S, Hanly E, Nicolini A, George AL, Geliebter J, Shin EJ, Suriano R, Carpi A, Tiwari RK.

Curr Med Chem. 2014;21(11):1351-60. Review.

PMID:
24304276
14.

Fine tuning and measurement of mechanical properties of crosslinked hyaluronic acid hydrogels as biomimetic scaffold coating in regenerative medicine.

Credi C, Biella S, De Marco C, Levi M, Suriano R, Turri S.

J Mech Behav Biomed Mater. 2014 Jan;29:309-16. doi: 10.1016/j.jmbbm.2013.09.025. Epub 2013 Oct 4.

PMID:
24140731
15.

Ex vivo derived primary melanoma cells: implications for immunotherapeutic vaccines.

Suriano R, Rajoria S, L George A, Geliebter J, Wallack M, Tiwari RK.

J Cancer. 2013 Jun 19;4(5):371-82. doi: 10.7150/jca.6625. Print 2013.

16.

The recovery of repeated-sprint exercise is associated with PCr resynthesis, while muscle pH and EMG amplitude remain depressed.

Mendez-Villanueva A, Edge J, Suriano R, Hamer P, Bishop D.

PLoS One. 2012;7(12):e51977. doi: 10.1371/journal.pone.0051977. Epub 2012 Dec 17.

17.

Hypoxia and estrogen are functionally equivalent in breast cancer-endothelial cell interdependence.

George AL, Rajoria S, Suriano R, Mittleman A, Tiwari RK.

Mol Cancer. 2012 Oct 22;11:80. doi: 10.1186/1476-4598-11-80.

18.

Molecular target based combinational therapeutic approaches in thyroid cancer.

Rajoria S, Suriano R, George AL, Kamat A, Schantz SP, Geliebter J, Tiwari RK.

J Transl Med. 2012 May 1;10:81. doi: 10.1186/1479-5876-10-81.

19.

Synthetic Toll like receptor-4 (TLR-4) agonist peptides as a novel class of adjuvants.

Shanmugam A, Rajoria S, George AL, Mittelman A, Suriano R, Tiwari RK.

PLoS One. 2012;7(2):e30839. doi: 10.1371/journal.pone.0030839. Epub 2012 Feb 20.

20.

Laparoscopic-assisted cystotomy and cystostomy for treatment of cystic calculus in a gelding.

Straticò P, Suriano R, Sciarrini C, Varasano V, Petrizzi L.

Vet Surg. 2012 Jul;41(5):634-7. doi: 10.1111/j.1532-950X.2011.00946.x. Epub 2012 Feb 8.

PMID:
22316294
21.

Estrogen activity as a preventive and therapeutic target in thyroid cancer.

Rajoria S, Suriano R, George AL, Shanmugam A, Jussim C, Shin EJ, Moscatello AL, Geliebter J, Carpi A, Tiwari RK.

Biomed Pharmacother. 2012 Mar;66(2):151-8. doi: 10.1016/j.biopha.2011.11.010. Epub 2011 Dec 28. Review.

PMID:
22285105
22.

Estrogen-mediated angiogenesis in thyroid tumor microenvironment is mediated through VEGF signaling pathways.

Kamat A, Rajoria S, George A, Suriano R, Shanmugam A, Megwalu U, Prakash PB, Tiwari R, Schantz S.

Arch Otolaryngol Head Neck Surg. 2011 Nov;137(11):1146-53. doi: 10.1001/archoto.2011.194.

PMID:
22106242
23.

Endothelial progenitor cell biology in disease and tissue regeneration.

George AL, Bangalore-Prakash P, Rajoria S, Suriano R, Shanmugam A, Mittelman A, Tiwari RK.

J Hematol Oncol. 2011 May 24;4:24. doi: 10.1186/1756-8722-4-24. Review.

24.

Identification of PSA peptide mimotopes using phage display peptide library.

Shanmugam A, Suriano R, Chaudhuri D, Rajoria S, George A, Mittelman A, Tiwari RK.

Peptides. 2011 Jun;32(6):1097-102. doi: 10.1016/j.peptides.2011.04.018. Epub 2011 Apr 22.

PMID:
21539876
25.

Estradiol-mediated tumor neo-vascularization.

Rajoria S, Suriano R, Wilson YL, George AL, Geliebter J, Schantz SP, Tiwari RK.

Oncol Lett. 2011 May;2(3):453-457. Epub 2011 Mar 21.

26.

Oocyte donation programs: strategy for improving results.

Borini A, Suriano R, Barberi M, Dal Prato L, Bulletti C.

Ann N Y Acad Sci. 2011 Mar;1221:27-31. doi: 10.1111/j.1749-6632.2010.05934.x.

PMID:
21401626
27.

Estrogen induced metastatic modulators MMP-2 and MMP-9 are targets of 3,3'-diindolylmethane in thyroid cancer.

Rajoria S, Suriano R, George A, Shanmugam A, Schantz SP, Geliebter J, Tiwari RK.

PLoS One. 2011 Jan 18;6(1):e15879. doi: 10.1371/journal.pone.0015879.

28.

3,3'-diindolylmethane modulates estrogen metabolism in patients with thyroid proliferative disease: a pilot study.

Rajoria S, Suriano R, Parmar PS, Wilson YL, Megwalu U, Moscatello A, Bradlow HL, Sepkovic DW, Geliebter J, Schantz SP, Tiwari RK.

Thyroid. 2011 Mar;21(3):299-304. doi: 10.1089/thy.2010.0245. Epub 2011 Jan 22.

29.

3,3'-diindolylmethane inhibits migration and invasion of human cancer cells through combined suppression of ERK and AKT pathways.

Rajoria S, Suriano R, Wilson YL, Schantz SP, Moscatello A, Geliebter J, Tiwari RK.

Oncol Rep. 2011 Feb;25(2):491-7. doi: 10.3892/or.2010.1076. Epub 2010 Dec 7.

PMID:
21152869
30.

Identification of peptide mimotopes of gp96 using single-chain antibody library.

Shanmugam A, Suriano R, Goswami N, Chaudhuri D, Ashok BT, Rajoria S, George AL, Mittelman A, Tiwari RK.

Cell Stress Chaperones. 2011 Mar;16(2):225-34. doi: 10.1007/s12192-010-0234-6. Epub 2010 Oct 16.

31.

Surface properties of femtosecond laser ablated PMMA.

Marco CD, Eaton SM, Suriano R, Turri S, Levi M, Ramponi R, Cerullo G, Osellame R.

ACS Appl Mater Interfaces. 2010 Aug;2(8):2377-84. doi: 10.1021/am100393e.

PMID:
20735111
32.

Low-dose estrogen and drospirenone combination: effects on glycoinsulinemic metabolism and other cardiovascular risk factors in healthy postmenopausal women.

Villa P, Suriano R, Ricciardi L, Tagliaferri V, De Cicco S, De Franciscis P, Colacurci N, Lanzone A.

Fertil Steril. 2011 Jan;95(1):158-63. doi: 10.1016/j.fertnstert.2010.07.001. Epub 2010 Aug 21.

PMID:
20728082
33.

Combined cycle and run performance is maximised when the cycle is completed at the highest sustainable intensity.

Suriano R, Bishop D.

Eur J Appl Physiol. 2010 Nov;110(4):753-60. doi: 10.1007/s00421-010-1547-y. Epub 2010 Jun 30.

PMID:
20589390
34.

Fasting and post-methionine homocysteine levels in Alzheimers disease and vascular dementia.

Villa P, Bosco P, Ferri R, Perri C, Suriano R, Costantini B, Macrì F, Proto C, Cento RM, Lanzone A.

Int J Vitam Nutr Res. 2009 May;79(3):166-72. doi: 10.1024/0300-9831.79.3.166.

PMID:
20209467
35.

Metastatic phenotype is regulated by estrogen in thyroid cells.

Rajoria S, Suriano R, Shanmugam A, Wilson YL, Schantz SP, Geliebter J, Tiwari RK.

Thyroid. 2010 Jan;20(1):33-41. doi: 10.1089/thy.2009.0296.

36.

Sialic acid content of tissue-specific gp96 and its potential role in modulating gp96-macrophage interactions.

Suriano R, Ghosh SK, Chaudhuri D, Mittelman A, Banerjee A, Tiwari RK.

Glycobiology. 2009 Dec;19(12):1427-35. doi: 10.1093/glycob/cwp096. Epub 2009 Jul 3.

PMID:
19578160
37.

Physiological attributes of triathletes.

Suriano R, Bishop D.

J Sci Med Sport. 2010 May;13(3):340-7. doi: 10.1016/j.jsams.2009.03.008. Epub 2009 Jul 4. Review.

PMID:
19577959
38.

Targeting the immune system in cancer.

Chaudhuri D, Suriano R, Mittelman A, Tiwari RK.

Curr Pharm Biotechnol. 2009 Feb;10(2):166-84. Review.

PMID:
19199949
39.

The differential effect of the phytoestrogen genistein on cardiovascular risk factors in postmenopausal women: relationship with the metabolic status.

Villa P, Costantini B, Suriano R, Perri C, Macrì F, Ricciardi L, Panunzi S, Lanzone A.

J Clin Endocrinol Metab. 2009 Feb;94(2):552-8. doi: 10.1210/jc.2008-0735. Epub 2008 Nov 18.

PMID:
19017760
40.

Low- and standard-estrogen dosage in oral therapy: dose-dependent effects on insulin and lipid metabolism in healthy postmenopausal women.

Villa P, Sagnella F, Perri C, Suriano R, Costantini B, Macrí F, Ricciardi L, Lanzone A.

Climacteric. 2008;11(6):498-508. doi: 10.1080/13697130802471058.

PMID:
18991077
41.

17Beta-estradiol mobilizes bone marrow-derived endothelial progenitor cells to tumors.

Suriano R, Chaudhuri D, Johnson RS, Lambers E, Ashok BT, Kishore R, Tiwari RK.

Cancer Res. 2008 Aug 1;68(15):6038-42. doi: 10.1158/0008-5472.CAN-08-1009.

42.

Effects of cycle strategy and fibre composition on muscle glycogen depletion pattern and subsequent running economy.

Suriano R, Edge J, Bishop D.

Br J Sports Med. 2010 May;44(6):443-8. doi: 10.1136/bjsm.2007.046029. Epub 2008 May 16.

PMID:
18487251
43.

Estro-progestin supplementation enhances the growth hormone secretory responsiveness to ghrelin infusion in postmenopausal women.

Villa P, Costantini B, Perri C, Suriano R, Ricciardi L, Lanzone A.

Fertil Steril. 2008 Feb;89(2):398-403. Epub 2007 May 16.

PMID:
17509580
44.

Hyperhomocysteinemia and cardiovascular risk in postmenopausal women: the role of folate supplementation.

Villa P, Suriano R, Costantini B, Macrì F, Ricciardi L, Campagna G, Lanzone A.

Clin Chem Lab Med. 2007;45(2):130-5. Review.

PMID:
17311496
45.

Surface behavior and molecular recognition in DNA microarrays from N,N-dimethylacrylamide terpolymers with activated esters as linking groups.

Suriano R, Levi M, Pirri G, Damin F, Chiari M, Turri S.

Macromol Biosci. 2006 Sep 15;6(9):719-29.

PMID:
16967476
46.

Variable power output during cycling improves subsequent treadmill run time to exhaustion.

Suriano R, Vercruyssen F, Bishop D, Brisswalter J.

J Sci Med Sport. 2007 Aug;10(4):244-51. Epub 2006 Aug 17.

PMID:
16914374
47.

Pilot study using SELDI-TOF-MS based proteomic profile for the identification of diagnostic biomarkers of thyroid proliferative diseases.

Suriano R, Lin Y, Ashok BT, Schaefer SD, Schantz SP, Geliebter J, Tiwari RK.

J Proteome Res. 2006 Apr;5(4):856-61.

PMID:
16602693
48.

Core temperature and hydration status during an Ironman triathlon.

Laursen PB, Suriano R, Quod MJ, Lee H, Abbiss CR, Nosaka K, Martin DT, Bishop D.

Br J Sports Med. 2006 Apr;40(4):320-5; discussion 325.

49.

Effect of metformin on the growth hormone response to growth hormone-releasing hormone in obese women with polycystic ovary syndrome.

Guido M, Romualdi D, Giuliani M, Suriano R, Tienforti D, Costantini B, Lanzone A.

Fertil Steril. 2005 Nov;84(5):1470-6.

PMID:
16275246
50.

Differences in glycosylation patterns of heat shock protein, gp96: implications for prostate cancer prevention.

Suriano R, Ghosh SK, Ashok BT, Mittelman A, Chen Y, Banerjee A, Tiwari RK.

Cancer Res. 2005 Jul 15;65(14):6466-75.

Supplemental Content

Loading ...
Support Center